SBC Medical Group Holdings Inc (SBC) stock
SBCNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31Also trades as SBCWW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 12/3039% below fair value
$5.34+0.10 (+1.91%)
Close on Nov 12, 2026Market cap $549.20MP/E 11.4Yield –
SBC Medical EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
SBC Medical's EPS for the twelve months ending Jun 30, 2026 was $0.47, up 46.9% year over year. For fiscal 2025 it was $0.50, up 4.2% from the year before.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $0.50 | +4.2% |
| FY2024 | Dec 31, 2024 | $0.48 | +14.3% |
| FY2023 | Dec 31, 2023 | $0.42 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $0.10 | +400.0% |
| Q1 FY2026 | Mar 31, 2026 | $0.11 | -47.6% |
| Q4 FY2025 | Dec 31, 2025 | $0.14 | +133.3% |
| Q3 FY2025 | Sep 30, 2025 | $0.12 | +300.0% |
| Q2 FY2025 | Jun 30, 2025 | $0.02 | -90.0% |
| Q1 FY2025 | Mar 31, 2025 | $0.21 | +5.0% |
| Q4 FY2024 | Dec 31, 2024 | $0.06 | -60.0% |
| Q3 FY2024 | Sep 30, 2024 | $0.03 | -66.7% |
| Q2 FY2024 | Jun 30, 2024 | $0.20 | – |
| Q1 FY2024 | Mar 31, 2024 | $0.20 | – |
| Q4 FY2023 | Dec 31, 2023 | $0.15 | – |
| Q3 FY2023 | Sep 30, 2023 | $0.09 | – |
| Q2 FY2022 | Jun 30, 2022 | $0.00 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?